Centre Issues Guidelines For India’s Mass COVID Vaccination Drive

Picture credit: Zee News

New Delhi: The Centre on Monday released detailed guidelines for India’s mass inoculation drive that will begin once the frontrunner candidates will be available for emergency use.

Under phase one of the vaccination drive, the government is planning to vaccinate nearly 30 crore people, including healthcare & frontline workers, people above 50 years of age and those under 50 with comorbidities.

Here’s a snapshot of COVID-19 vaccination drive:
  • Around 100 to 200 people will be vaccinated during each session per day.
  • People will be monitored for 30 minutes after administering the shots for any adverse event.
  • The vaccination team will consist of five members.
  • If the session site has adequate logistics and space available for waiting and observation room, one more vaccinator officer can be added to create a session for 200 beneficiaries.
  • Covid Vaccine Intelligence Network (Co-WIN) system — a digitalised platform — will be used to track enlisted beneficiaries for the inoculation and anti-coronavirus vaccines on a real-time basis.
  • Twelve photo-identity documents, including Voter ID, Aadhaar card, driving license, passport and pension document will be required for self-registration on the Co-WIN website.
  • At the vaccination site, only pre-registered beneficiaries will be vaccinated in accordance with the prioritisation, and there will be no provision for on the-spot registrations.
  • The states have been asked to allocate the vaccine from one manufacturer to a district to avoid mixing of different vaccines in the field.
  • All measures will be taken to avoid exposing the vaccine carrier, vaccine vials or ice packs to direct sunlight.
  • Vaccines and diluents will be kept inside the vaccine carrier with the lid closed until a beneficiary comes to the centre for vaccination.
  • States have been directed to implement an integrated 360-degree comprehensive advocacy communication and social mobilisation strategy to address the challenges surrounding vaccine rollout progress and benefits.

About the author


TL Bureau

Add Comment

Leave a Comment